Showing results (231-240 of 271) with videos related to

Sort By:
Pageof 28
Gastrointestinal Cancer Research : GCR|May 23, 2009
Localized gastric or gastroesophageal cancer - chemoradiation is a pertinent component of adjuvant treatment for patients at high risk of relapseLeonard L Gunderson, Matthew D Callister, Dawn E Jaroszewski, et al.
The New England Journal of Medicine|March 14, 1991
Effective surgical adjuvant therapy for high-risk rectal carcinomaJ E Krook, C G Moertel, L L Gunderson, et al.
The New England Journal of Medicine|December 31, 1998
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancerD P Kelsen, R Ginsberg, T F Pajak, et al.
Plos Genetics|October 10, 2007
Power to detect risk alleles using genome-wide tag SNP panelsMichael A Eberle, Pauline C Ng, Kenneth Kuhn, et al.
Nature Genetics|October 20, 2014
Haplotype-resolved whole-genome sequencing by contiguity-preserving transposition and combinatorial indexingSasan Amini, Dmitry Pushkarev, Lena Christiansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancerDavid P Kelsen, Katryn A Winter, Leonard L Gunderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2004
Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130James A Martenson, Christopher G Willett, Daniel J Sargent, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1993
Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracilM L Foo, L L Gunderson, D M Nagorney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2012
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatinLeonard L Gunderson, Kathryn A Winter, Jaffer A Ajani, et al.
Pageof 28